Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Hypertension. 2021 Jun 21;78(3):629–643. doi: 10.1161/HYPERTENSIONAHA.121.17049

Figure 2:

Figure 2:

Forest plots. (A) There were no significant differences among individuals who took BBB-crossing drugs vs. non-BBB-crossing drugs on measures of mental status at baseline. (B) Individuals who took BBB-crossing drugs outperformed those who took non-BBB-crossing drugs on measures of verbal memory (recall) over time. (C) Individuals who took non-BBB-crossing drugs outperformed those who took BBB-crossing drugs on measures of attention over time. There were no significant differences among individuals who took BBB-crossing drugs vs. non-BBB-crossing drugs on measures of (D) executive function, (E) language, or (F) verbal memory (learning) over 3 years of follow-up.